Adam Veness
General Counsel chez DIANTHUS THERAPEUTICS, INC.
Fortune : - $ au 31/03/2024
Profil
Actuellement, Adam M. Veness occupe le poste de secrétaire, vice-président principal et directeur juridique d'Acceleron Pharma, Inc. Dans sa carrière antérieure, M. Veness a occupé le poste de directeur chez Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC. Adam M. Veness a obtenu un diplôme de premier cycle à l'université de Tulane (Louisiane) et un diplôme d'études supérieures à la faculté de droit de l'université de Boston.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
24/01/2024 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Adam Veness
Sociétés | Poste | Début |
---|---|---|
DIANTHUS THERAPEUTICS, INC. | General Counsel | 11/09/2023 |
Anciens postes connus de Adam Veness
Sociétés | Poste | Fin |
---|---|---|
CYTEIR THERAPEUTICS, INC. | General Counsel | 14/06/2023 |
ACCELERON PHARMA INC. | Compliance Officer | 01/06/2019 |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01/07/2014 |
Formation de Adam Veness
Tulane University (Louisiana) | Undergraduate Degree |
Boston University School of Law | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 2 |
---|---|
CYTEIR THERAPEUTICS, INC. | Health Technology |
DIANTHUS THERAPEUTICS, INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Acceleron Pharma, Inc.
Acceleron Pharma, Inc. BiotechnologyHealth Technology Acceleron Pharma, Inc. is a biopharmaceutical company, which engages in the discovery, development and commercialization of therapeutics to treat serious and rare diseases. Its product candidates include Luspatercept, designed to patients with chronic anemia associated within a wide range of blood diseases; ACE-083, designed for the treatment of focal muscle disorders; and Sotatercept, designed to treat pulmonary arterial hypertension. The company was founded by John L. Knopf and Thomas P. Maniatis in June 2003 and is headquartered in Cambridge, MA. | Health Technology |
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC
Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC Miscellaneous Commercial ServicesCommercial Services Mintz, Levin, Cohn, Ferris, Glovsky & Popeo PC provides legal services. The firm offers services to the communications, education, environmental, health, immigration, public finance, real estate and tax industries. The company was founded in 1933 and is headquartered in Boston, MA. | Commercial Services |